Cargando…
CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
Multiple sclerosis (MS) is an immune-mediated disease of the central nervous system, which leads, in many cases, to irreversible disability. More than 15 disease-modifying treatments (DMTs) are available for the treatment of MS. Clinical activity or activity at magnetic resonance imaging (MRI) are n...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291063/ https://www.ncbi.nlm.nih.gov/pubmed/32414131 http://dx.doi.org/10.3390/jcm9051450 |